Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7607207 | 0.82 | TP53 (0.55) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL29898330 | 0.81 | TP53 (0.75) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL4972255 | 0.81 | TP53 (0.68) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL39098 | 0.81 | TP53 (0.75) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL4972259 | 0.81 | TP53 (0.68) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL6005632 | 0.81 | MEN1 (0.58) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL11501360 | 0.81 | TP53 (0.53) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL9333655 | 0.81 | HTT (0.56) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL3430755 | 0.81 | MEN1 (0.58) | TP53MEN1KMT2AHTTAKR1C3 | |
| SCHEMBL8207397 | 0.81 | TP53 (0.53) | TP53MEN1KMT2AHTTAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102933195-B | Composition comprising a dibenzoylmethane screening agent and a merocyanine dicyano or cyanoacetate derivative, method for photostabilization of dibenzoylmethane screening agent | OREAL | 2015-04-01 | — | — | CN | claimed |
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | claimed |
| CN-102933195-A | Composition comprising a dibenzoylmethane screening agent and a merocyanine dicyano or cyanoacetate derivative, method for photostabilization of dibenzoylmethane screening agent | OREAL | 2013-02-13 | — | — | CN | claimed |
| CN-102883704-A | Composition comprising a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanine uv screening agent, method for photostabilizing said dibenzoylmethane screening agent | OREAL | 2013-01-16 | — | — | CN | claimed |
| WO-2012010554-A1 | USE OF COMPOUNDS RESULTING FROM A SUGAR POLYOL OR FROM A DEHYDROGENATED SUGAR POLYOL DERIVATIVE AS A UV-SCREENING AGENT; ANTISUN COMPOSITIONS CONTAINING SAME; AND NOVEL COMPOUNDS | L'OREAL (FR) | 2012-01-26 | — | — | WO | claimed |
| US-7534421-B2 | s-Triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | L'OREAL (FR) | 2009-05-19 | — | — | US | claimed |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | claimed |
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | L'OREAL (FR) | 2005-01-13 | — | — | US | claimed |
| US-20040258636-A1 | Novel s-triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | SOCIETE L'OREAL S.A. (FR) | 2004-12-23 | — | — | US | claimed |
| EP-1466908-A1 | S-tiazin-derivatives having at least one grafted para-aminobenzalmalonic acid salt and sun screening preparations comprising those derivatives | L'OREAL (FR) | 2004-10-13 | — | — | EP | claimed |
| CN-114760982-B | Composition comprising a cationic polysaccharide and an anionic antioxidant | 莱雅公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2024110352-A1 | HYDRATING COMPLEX AND USE IN MOISTURISING COMPOSITIONS | LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) | 2024-05-30 | — | — | WO | disclosed |
| WO-2023277194-A1 | SUNSCREEN W/O EMULSION | L'OREAL (FR) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022234092-A1 | Oil-in-water emulsion comprising a particular mixture of surfactants and the combination of at least one starch grafted with an acrylic polymer and of at least one starch not grafted with an acrylic polymer | L'OREAL (FR) | 2022-11-10 | — | — | WO | disclosed |
| EP-4076340-A1 | SUN CARE COMPOSITION | L'OREAL (FR) | 2022-10-26 | — | — | EP | disclosed |
| US-6517742-B1 | 2-(butyl 4'-ylaminobenzoate)-4,6-bis((1,3,3,3-tetramethyl-1 -((trimethylsilyl)oxy)disiloxanyl)propyl-3-ylamino)-s-triazine; s-triazine derivatives substituted by at least one silicone group; from cyanuric chloride | L'OREAL (FR) | 2003-02-11 | — | — | US | disclosed |
| CN-1355686-A | Micropigment mixture | CIBA SC HOLDING AG (CH) | 2002-06-26 | — | — | CN | disclosed |
| EP-0841341-B1 | Sunscreen agents, and cosmetic compositions containing them | OREAL (FR) | 1999-04-07 | — | — | EP | disclosed |
| EP-0841341-A1 | Sunscreen agents, and cosmetic compositions containing them | L'OREAL (FR) | 1998-05-13 | — | — | EP | disclosed |
| EP-0841341-A1 | Sunscreen agents, and cosmetic compositions containing them | L'OREAL (FR) | 1998-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | TYR, AAAS, ALAD | TP53 1686/4885MEN1 3700/4885KMT2A 1215/4885 |
| US-20040258636-A1 | Novel s-triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | TYR, KRT18, TST | TP53 143/4885MEN1 4041/4885KMT2A 495/4885 |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | TYR, AAAS, ALAD | TP53 1661/4885MEN1 3854/4885KMT2A 1027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.